<h4>Background</h4>The current expert view of the PCSK9 inhibitors' use in Egypt is still ambiguous.<h4>Main body</h4>Hyperlipidemia is an important, if not the most important, risk factor for the occurrence of atherosclerosis worldwide. This evidence concerns the gene PCSK9 and hyperlipidemia.